vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $217.5M, roughly 1.1× Tilray Brands, Inc.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -20.7%, a 25.1% gap on every dollar of revenue. On growth, CSW INDUSTRIALS, INC. posted the faster year-over-year revenue change (20.3% vs 3.1%). Over the past eight quarters, Tilray Brands, Inc.'s revenue compounded faster (7.5% CAGR vs 5.1%).

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

CSW vs TLRY — Head-to-Head

Bigger by revenue
CSW
CSW
1.1× larger
CSW
$233.0M
$217.5M
TLRY
Growing faster (revenue YoY)
CSW
CSW
+17.2% gap
CSW
20.3%
3.1%
TLRY
Higher net margin
CSW
CSW
25.1% more per $
CSW
4.4%
-20.7%
TLRY
Faster 2-yr revenue CAGR
TLRY
TLRY
Annualised
TLRY
7.5%
5.1%
CSW

Income Statement — Q3 FY2026 vs Q2 FY2026

Metric
CSW
CSW
TLRY
TLRY
Revenue
$233.0M
$217.5M
Net Profit
$10.3M
$-44.9M
Gross Margin
39.7%
26.4%
Operating Margin
7.4%
-10.2%
Net Margin
4.4%
-20.7%
Revenue YoY
20.3%
3.1%
Net Profit YoY
-61.9%
47.4%
EPS (diluted)
$0.62
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
TLRY
TLRY
Q4 25
$233.0M
$217.5M
Q3 25
$277.0M
$209.5M
Q2 25
$263.6M
$224.5M
Q1 25
$230.5M
$185.8M
Q4 24
$193.6M
$210.9M
Q3 24
$227.9M
$200.0M
Q2 24
$226.2M
$229.9M
Q1 24
$210.9M
$188.3M
Net Profit
CSW
CSW
TLRY
TLRY
Q4 25
$10.3M
$-44.9M
Q3 25
$40.7M
$-322.0K
Q2 25
$40.9M
$-1.3B
Q1 25
$35.1M
$-789.4M
Q4 24
$26.9M
$-85.3M
Q3 24
$36.1M
$-39.2M
Q2 24
$38.6M
$-31.7M
Q1 24
$31.8M
$-92.7M
Gross Margin
CSW
CSW
TLRY
TLRY
Q4 25
39.7%
26.4%
Q3 25
43.0%
27.4%
Q2 25
43.8%
30.1%
Q1 25
44.2%
28.0%
Q4 24
41.4%
29.0%
Q3 24
45.6%
29.8%
Q2 24
47.5%
35.8%
Q1 24
44.4%
26.2%
Operating Margin
CSW
CSW
TLRY
TLRY
Q4 25
7.4%
-10.2%
Q3 25
20.5%
1.0%
Q2 25
20.8%
-643.1%
Q1 25
19.5%
-409.0%
Q4 24
15.3%
-20.0%
Q3 24
22.6%
-18.3%
Q2 24
24.3%
-7.2%
Q1 24
21.0%
-43.6%
Net Margin
CSW
CSW
TLRY
TLRY
Q4 25
4.4%
-20.7%
Q3 25
14.7%
-0.2%
Q2 25
15.5%
-566.9%
Q1 25
15.2%
-424.9%
Q4 24
13.9%
-40.5%
Q3 24
15.8%
-19.6%
Q2 24
17.1%
-13.8%
Q1 24
15.1%
-49.2%
EPS (diluted)
CSW
CSW
TLRY
TLRY
Q4 25
$0.62
$-0.41
Q3 25
$2.41
$0.00
Q2 25
$2.43
$7.26
Q1 25
$2.05
$-8.69
Q4 24
$1.60
$-0.99
Q3 24
$2.26
$-0.04
Q2 24
$2.47
$-0.04
Q1 24
$2.03
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$40.2M
$291.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$1.6B
Total Assets
$2.3B
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
TLRY
TLRY
Q4 25
$40.2M
$291.6M
Q3 25
$31.5M
$264.8M
Q2 25
$38.0M
$256.4M
Q1 25
$225.8M
Q4 24
$213.8M
$252.2M
Q3 24
$273.2M
$280.1M
Q2 24
$18.9M
$260.5M
Q1 24
$22.2M
$225.9M
Total Debt
CSW
CSW
TLRY
TLRY
Q4 25
Q3 25
Q2 25
Q1 25
$800.1M
Q4 24
Q3 24
Q2 24
Q1 24
$166.0M
Stockholders' Equity
CSW
CSW
TLRY
TLRY
Q4 25
$1.1B
$1.6B
Q3 25
$1.1B
$1.5B
Q2 25
$1.1B
$1.5B
Q1 25
$1.1B
$2.7B
Q4 24
$1.0B
$3.5B
Q3 24
$1.0B
$3.5B
Q2 24
$650.2M
$3.4B
Q1 24
$615.7M
$3.4B
Total Assets
CSW
CSW
TLRY
TLRY
Q4 25
$2.3B
$2.1B
Q3 25
$1.5B
$2.1B
Q2 25
$1.5B
$2.1B
Q1 25
$1.4B
Q4 24
$1.4B
$4.2B
Q3 24
$1.4B
$4.3B
Q2 24
$1.1B
$4.2B
Q1 24
$1.0B
$4.2B
Debt / Equity
CSW
CSW
TLRY
TLRY
Q4 25
Q3 25
Q2 25
Q1 25
0.75×
Q4 24
Q3 24
Q2 24
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
TLRY
TLRY
Operating Cash FlowLast quarter
$28.9M
$-8.5M
Free Cash FlowOCF − Capex
$22.7M
FCF MarginFCF / Revenue
9.8%
Capex IntensityCapex / Revenue
2.6%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$162.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
TLRY
TLRY
Q4 25
$28.9M
$-8.5M
Q3 25
$61.8M
$-1.3M
Q2 25
$60.6M
$-12.8M
Q1 25
$27.3M
$-5.8M
Q4 24
$11.6M
$-40.7M
Q3 24
$66.8M
$-35.3M
Q2 24
$62.7M
$30.7M
Q1 24
$22.4M
$-15.4M
Free Cash Flow
CSW
CSW
TLRY
TLRY
Q4 25
$22.7M
Q3 25
$58.7M
Q2 25
$57.7M
$-19.1M
Q1 25
$22.8M
$-20.2M
Q4 24
$8.5M
$-46.2M
Q3 24
$61.3M
$-42.0M
Q2 24
$59.6M
$21.0M
Q1 24
$17.5M
$-24.9M
FCF Margin
CSW
CSW
TLRY
TLRY
Q4 25
9.8%
Q3 25
21.2%
Q2 25
21.9%
-8.5%
Q1 25
9.9%
-10.9%
Q4 24
4.4%
-21.9%
Q3 24
26.9%
-21.0%
Q2 24
26.3%
9.1%
Q1 24
8.3%
-13.2%
Capex Intensity
CSW
CSW
TLRY
TLRY
Q4 25
2.6%
Q3 25
1.1%
Q2 25
1.1%
2.8%
Q1 25
2.0%
7.8%
Q4 24
1.6%
2.6%
Q3 24
2.4%
3.4%
Q2 24
1.4%
4.2%
Q1 24
2.3%
5.1%
Cash Conversion
CSW
CSW
TLRY
TLRY
Q4 25
2.81×
Q3 25
1.52×
Q2 25
1.48×
Q1 25
0.78×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons